J.P. Chiron

1.1k total citations
47 papers, 774 citations indexed

About

J.P. Chiron is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, J.P. Chiron has authored 47 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 17 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in J.P. Chiron's work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). J.P. Chiron is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). J.P. Chiron collaborates with scholars based in France, Senegal and Burkina Faso. J.P. Chiron's co-authors include Pierre Coursaget, B Yvonnet, I. Diop‐Mar, J. Chotard, M Sarr, R N'Doye, I. Diop Mar, F. Denis, E. H. Relyveld and Sylvie Ledru and has published in prestigious journals such as The Lancet, Infection and Immunity and International Journal of Cancer.

In The Last Decade

J.P. Chiron

46 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Chiron France 13 597 397 185 114 101 47 774
Joan P. Giles United States 17 1.1k 1.8× 684 1.7× 380 2.1× 156 1.4× 190 1.9× 27 1.5k
R. Trivello Italy 20 857 1.4× 559 1.4× 228 1.2× 94 0.8× 153 1.5× 55 1.1k
Francis J. Mahoney United States 16 744 1.2× 504 1.3× 163 0.9× 207 1.8× 53 0.5× 22 976
Keith R. Perry United Kingdom 17 341 0.6× 221 0.6× 313 1.7× 44 0.4× 45 0.4× 26 684
S. Ramia Saudi Arabia 25 1.3k 2.2× 1.2k 3.1× 383 2.1× 31 0.3× 59 0.6× 107 1.8k
Tessa Braeckman Belgium 13 212 0.4× 180 0.5× 323 1.7× 179 1.6× 116 1.1× 21 661
K. J. Bart United States 12 338 0.6× 73 0.2× 160 0.9× 167 1.5× 84 0.8× 16 589
John V. Parry United Kingdom 16 598 1.0× 226 0.6× 459 2.5× 32 0.3× 69 0.7× 33 922
Daniel Desgrandchamps Switzerland 12 403 0.7× 53 0.1× 167 0.9× 114 1.0× 60 0.6× 25 645
N. A. Halsey United States 11 375 0.6× 75 0.2× 183 1.0× 135 1.2× 77 0.8× 13 517

Countries citing papers authored by J.P. Chiron

Since Specialization
Citations

This map shows the geographic impact of J.P. Chiron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Chiron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Chiron more than expected).

Fields of papers citing papers by J.P. Chiron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Chiron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Chiron. The network helps show where J.P. Chiron may publish in the future.

Co-authorship network of co-authors of J.P. Chiron

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Chiron. A scholar is included among the top collaborators of J.P. Chiron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Chiron. J.P. Chiron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diagbouga, Serge, J.P. Chiron, Oumarou Sanou, & Éric Ledru. (2001). Alteration in CD29high CD4+ Lymphocyte Subset is a Common Feature of Early HIV Disease and of Active Tuberculosis. Scandinavian Journal of Immunology. 53(1). 79–84. 2 indexed citations
2.
Chiron, J.P., Pierre Coursaget, & B Yvonnet. (1998). [Philippe Maupas : hepatitis B vaccine discoverer].. PubMed. 46(319). 279–92. 2 indexed citations
3.
Emond, Patrick, Lars Farde, Sylvie Chalon, et al.. (1998). Toxicity, Mutagenicity, and Behavioral Effects of β-CIT, a Ligand for Dopamine Transporter Exploration by SPECT. Nuclear Medicine and Biology. 25(4). 405–409. 4 indexed citations
4.
Ledru, Sylvie, et al.. (1996). Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tubercle and Lung Disease. 77(5). 429–436. 31 indexed citations
5.
Ledru, Éric, et al.. (1995). A study of Toxoplasma and Cytomegalovirus serology in tuberculosis and in HIV-infected patients in Burkina Faso. Acta Tropica. 59(2). 149–154. 16 indexed citations
6.
Ledru, Éric, et al.. (1994). Eosinophils: a putative marker of immunodepression in HIV-infected African patients with tuberculosis?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(1). 117–118. 4 indexed citations
7.
Coursaget, Pierre, E. H. Relyveld, A. Brizard, et al.. (1992). Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine. Vaccine. 10(5). 319–321. 15 indexed citations
8.
Coursaget, Pierre, Bernard Fritzell, Christine Blondeau, et al.. (1992). Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine. 10(6). 379–382. 11 indexed citations
9.
Coursaget, Pierre, et al.. (1991). Simultaneous injection of hepatitis B and measles vaccines. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85(6). 788–788. 7 indexed citations
10.
Coursaget, Pierre, Yves Buisson, B Yvonnet, et al.. (1990). Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization. Research in Virology. 141(5). 563–570. 10 indexed citations
11.
Coursaget, Pierre, R Kastally, B Yvonnet, et al.. (1990). Prevalence of hepatitis C virus infection in Africa: Anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Research in Virology. 141(4). 449–454. 38 indexed citations
12.
Coursaget, Pierre, B Yvonnet, J. Chotard, et al.. (1990). Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virus. Vaccine. 8. S15–S17. 9 indexed citations
13.
Coursaget, Pierre, J. Chotard, I. Diop Mar, et al.. (1987). HBsAG POSITIVE REACTIVITY IN MAN NOT DUE TO HEPATITIS B VIRUS. The Lancet. 330(8572). 1354–1358. 76 indexed citations
14.
Coursaget, Pierre, J. Chotard, I. Diop‐Mar, et al.. (1986). SEVEN-YEAR STUDY OF HEPATITIS B VACCINE EFFICACY IN INFANTS FROM AN ENDEMIC AREA (SENEGAL). The Lancet. 328(8516). 1143–1145. 125 indexed citations
15.
Perrin, J.H., et al.. (1984). Vaccination du nouveau-né contre l'hépatite B au Burundi.. 1 indexed citations
16.
Cadoz, M., et al.. (1979). [The prognosis and treatment of pneumococcal meningitis in Africa. 402 cases (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(8). 573–6. 3 indexed citations
17.
Denis, F., et al.. (1979). Les streptocoques du groupe B chez la femme enceinte et le nouveau-né en afrique de l'Ouest. Médecine et Maladies Infectieuses. 9(5). 318–321. 1 indexed citations
18.
Chiron, J.P., et al.. (1977). Incidence des shigelloses en milieu hospitalier dakarois sur une période de quatre ans (1973-1976).. 22(2). 1 indexed citations
19.
Chiron, J.P., et al.. (1977). Ultrastructure des bactériophages de Listeria monocytogenes.. Comptes rendus des séances de la Société de biologie et de ses filiales. 171(2). 6 indexed citations
20.
Chiron, J.P., et al.. (1977). [Incidence of shigelloses in Dakar hospitals in a 4-year period (1973-1976)].. PubMed. 22(2). 174–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026